Home Cart Sign in  
Chemical Structure| 301326-22-7 Chemical Structure| 301326-22-7

Structure of CH-223191
CAS No.: 301326-22-7

Chemical Structure| 301326-22-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

CH-223191 is a potent and specific antagonist of the aryl hydrocarbon receptor (AhR). It inhibits TCDD-mediated nuclear translocation and DNA binding of AhR, and suppresses TCDD-induced luciferase activity with an IC50 of 0.03 μM.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of CH-223191

CAS No. :301326-22-7
Formula : C19H19N5O
M.W : 333.39
SMILES Code : O=C(C1=CC=NN1C)NC2=CC=C(N=NC3=CC=CC=C3C)C=C2C
MDL No. :MFCD00377884
InChI Key :LKTNEXPODAWWFM-UHFFFAOYSA-N
Pubchem ID :3091786

Safety of CH-223191

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P264-P270-P301+P312-P330-P501

Isoform Comparison

Biological Activity

Target
  • AhR

    AhR, IC50:30 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
3T3-L1 adipocytes 3.4 µM 24 h To investigate the effect of PCB-77 on TNF-α expression in adipocytes, results showed that PCB-77 increased TNF-α expression through an AhR-dependent mechanism. PMC3553436
CD8 T cells 30 μM 72 h To evaluate the effect of CH-223191 on IFN γ production in CD8 T cells. Results showed that CH-223191 significantly suppressed IFN γ production. PMC9841318
Hs578T cells 10 μM 48 h Reduced ALDH1 activity and decreased the percentage of ALDHhigh cells PMC4794823
SUM149 cells 10 μM 48 h Reduced ALDH1 activity and decreased the percentage of ALDHhigh cells PMC4794823
U937 macrophages 10 µM 24 h To test the inhibitory effect of CH-223191 on TCDD and CSE-induced inflammatory responses, results showed that CH-223191 significantly suppressed the expression of inflammatory genes induced by TCDD and CSE. PMC3098318
H4G1.1c3 cells 10 µM 12 h CH-223191 suppressed the GFP expression induced by BaP and FICZ, indicating that CH-223191 is an AHR antagonist. PMC10606571
Caco-2 cells 10 μM 24 h Inhibit AHR activity to study its effect on IL10R1 expression PMC5515702
CD4+ T cells 10 μM 72 h CH223191 almost completely abolished alpinetin-promoted Treg differentiation PMC6117360
EL-4 cells 10 μM 24 h CH223191 almost offset alpinetin-mediated increase of CYP1A1 expression PMC6117360
DLD1 colon cancer cells 10 µM 2 days Reduced the proliferation of colon cancer cells PMC6719621

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice obesity model oral 10 mg/kg Once daily, starting 1 week before administration of vehicle or PCB-77 and continued throughout the study To investigate the effect of CH-223191 on PCB-77-induced glucose and insulin intolerance, results showed that CH-223191 blocked these effects of PCB-77. PMC3553436
Mice Tiparp-/- or WT mice Intraperitoneal injection 10 mg/kg Days 1 and 3 CH223191 cotreatment reduced 3MC-induced ALT activity and epididymal adipose tissue loss, but did not completely prevent 3MC-induced chylous ascites. PMC6540065
Mice Tet2ΔV A V mice Intraperitoneal injection 300 μg/mouse 5 days per week for 5 weeks To evaluate the effect of CH-223191 on AIH-like pathology. Results showed that CH-223191 significantly suppressed the development of AIH-like pathology. PMC9841318
mice ApoE −/− mice intraperitoneal injection 5 mg/kg weekly for 60 days To test the inhibitory effect of CH-223191 on TCDD-induced atherosclerotic plaque formation, results showed that CH-223191 significantly reduced TCDD-induced atherosclerotic plaque formation. PMC3098318
Mice B6. AhRfl/f LysM- Cre+/− mice Intraperitoneal injection 100μg/mouse Single injection To detect the effect of AhR on tolerance induced by apoptotic cells in vivo, results showed that AhR deletion led to enhanced immune responses. PMC5976527
Mice DSS-induced colitis model Intraperitoneal injection 10 mg/kg Once daily for 10 days CH223191 almost reversed alpinetin-alleviated UC symptoms and prevented alpinetin-induced Treg cells and regulation of miR-302/DNMT-1/CREB signals PMC6117360

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.00mL

0.60mL

0.30mL

15.00mL

3.00mL

1.50mL

30.00mL

6.00mL

3.00mL

References

 

Historical Records

Categories